Green synthesis of silver nanoparticles for the targeted delivery to HER2-overexpressing cancer cells

被引：0
|
作者：
Shipunova, V. [1 ,2 ]
Belova, M. [3 ]
Komedchikova, E. [1 ]
Babenyshev, A. [4 ]
Deyev, S. [1 ,2 ]
机构：
[1] RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia
[2] Natl Res Nucl Univ MEPhI, Moscow, Russia
[3] Russian State Agr Univ, Moscow Timiryazev Agr Acad, Moscow, Russia
[4] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia
来源：
FEBS OPEN BIO | 2019年 / 9卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-36-035
引用
收藏
页码：381 / 381
页数：1
相关论文
共 50 条
  • [41] Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer
    Emde, Anna
    Koestler, Wolfgang J.
    Yarden, Yosef
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 : E49 - E57
  • [42] In vitro assessment of the effects of anti-HER2 monoclonal antibodies on proliferation of HER2-overexpressing breast cancer cells
    Tahmasebi, Fathollah
    Kazemi, Tohid
    Amiri, Mohammad Mehdi
    Khoshnoodi, Jalal
    Mahmoudian, Jafar
    Bayat, Ali Ahmad
    Jeddi-Tehrani, Mahmood
    Rabbani, Hodjatallah
    Shokri, Fazel
    IMMUNOTHERAPY, 2014, 6 (01) : 43 - 49
  • [43] Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer
    Laginha, Kimberley M.
    Moase, Elaine H.
    Yu, Ning
    Huang, Anthony
    Allen, T. M.
    JOURNAL OF DRUG TARGETING, 2008, 16 (7-8) : 605 - 610
  • [44] The Role of HER2-targeted Therapies in Women with HER2-Overexpressing Metastatic Breast Cancer (vol 16, pg 236, 2009)
    Dent
    CURRENT ONCOLOGY, 2009, 16 (05) : 295 - 295
  • [45] Anti-HER2 immunoliposomes for selective delivery of electron paramagnetic resonance imaging probes to HER2-overexpressing breast tumor cells
    Scott R. Burks
    Luciana F. Macedo
    Eugene D. Barth
    Katherine H. Tkaczuk
    Stuart S. Martin
    Gerald M. Rosen
    Howard J. Halpern
    Angela M. Brodie
    Joseph P. Y. Kao
    Breast Cancer Research and Treatment, 2010, 124 : 121 - 131
  • [46] The effects of HER2 monoclonal antibody in women with HER2-overexpressing metastatic breast cancer
    Boer R.
    Breast Cancer Research, 1 (1)
  • [47] Anti-HER2 immunoliposomes for selective delivery of electron paramagnetic resonance imaging probes to HER2-overexpressing breast tumor cells
    Burks, Scott R.
    Macedo, Luciana F.
    Barth, Eugene D.
    Tkaczuk, Katherine H.
    Martin, Stuart S.
    Rosen, Gerald M.
    Halpern, Howard J.
    Brodie, Angela M.
    Kao, Joseph P. Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (01) : 121 - 131
  • [48] Mechanisms of Action and Biological Significance of HER2 Mutations in HER2-Overexpressing Breast Cancer
    Boulbes, D. R.
    Jin, Q.
    Arold, S. T.
    Ladbury, J. E.
    Yu, D.
    Esteva, F. J.
    CANCER RESEARCH, 2011, 71
  • [49] Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
    Quanri Jin
    Linda X Yuan
    Delphine Boulbes
    Jong Min Baek
    Ying Nai Wang
    Daniel Gomez-Cabello
    David H Hawke
    Sai Ching Yeung
    Mong Hong Lee
    Gabriel N Hortobagyi
    Mien Chie Hung
    Francisco J Esteva
    Breast Cancer Research, 12
  • [50] Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
    Jin, Quanri
    Yuan, Linda X.
    Boulbes, Delphine
    Baek, Jong Min
    Wang, Ying Nai
    Gomez-Cabello, Daniel
    Hawke, David H.
    Yeung, Sai Ching
    Lee, Mong Hong
    Hortobagyi, Gabriel N.
    Hung, Mien Chie
    Esteva, Francisco J.
    BREAST CANCER RESEARCH, 2010, 12 (06):
12345